In Russia was the first drug for the treatment COVID-19

The company “Chromis”, resident of the biomedical technologies Cluster of the SKOLKOVO Foundation, received a registration certificate of Ministry of health of the Russian Federation on drug favipiravir. This is the first Russian antivirus preparation of direct actions that violate the mechanisms of reproduction of coronavirus, the report said SKOLKOVO.

Research favipiravir confirmed that the efficacy exceeds the threshold of 80%. In 68% of patients who took favipiravir, the body temperature was normalized earlier (on day 3) than in the control group (on day 6). On average, the liberation of the body from the virus as a result of the use of favipiravir happened for 4 days, while in the group of standard therapy, the average duration is 9 days. Favipiravir has been well studied as of 2014 used in Japan against severe forms of influenza.

In early April, the Supervisory Board of the Russian direct investment Fund (RDIF) approved the establishment of a joint venture (JV) “Chromis” group of companies “Chemrar” for the production of favipiravir and other sorts of innovative medicines, including based on it.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]